Teza Capital Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-14,796
Closed -$263K 335
2025
Q1
$263K Buy
+14,796
New +$319K 0.12% 295
2024
Q4
Sell
-15,576
Closed -$486K 553
2024
Q3
$486K Sell
15,576
-1,063
-6% -$26.4K 0.05% 389
2024
Q2
$258K Sell
16,639
-645
-4% -$7.8K 0.03% 483
2024
Q1
$183K Sell
17,284
-986
-5% -$9.86K 0.02% 525
2023
Q4
$219K Buy
+18,270
New +$150K 0.04% 482

Other funds holding CDNA

Teza Capital Management's CDNA Position: Q2 2025 in Review

Teza Capital Management sold out of CareDx (CDNA) in Q2 2025, closing a stake of 14,796 shares — an estimated $263K sold.

Teza Capital Management first reported a position in CDNA in Q4 2023 and held it in 5 quarters. The position peaked at $486K in Q3 2024. 197 funds tracked by Wall St. Rank hold CDNA as of Q2 2025.

  • Teza Capital Management reported no remaining CareDx position as of Q2 2025 after selling out during the quarter.
  • Teza Capital Management sold 14,796 CareDx shares in Q2 2025, an estimated $263K.
  • Teza Capital Management first reported a position in CareDx in Q4 2023 and held it in 5 quarters.
  • Teza Capital Management's CareDx position peaked at $486K in Q3 2024.
  • 197 funds tracked by Wall St. Rank held CareDx as of Q2 2025.

Based on Teza Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.